ARFG2_HUMAN - dbPTM
ARFG2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ARFG2_HUMAN
UniProt AC Q8N6H7
Protein Name ADP-ribosylation factor GTPase-activating protein 2
Gene Name ARFGAP2
Organism Homo sapiens (Human).
Sequence Length 521
Subcellular Localization Cytoplasm . Golgi apparatus membrane
Peripheral membrane protein
Cytoplasmic side . Also found on peripheral punctate structures likely to be endoplasmic reticulum-Golgi intermediate compartment.
Protein Description GTPase-activating protein (GAP) for ADP ribosylation factor 1 (ARF1). Implicated in coatomer-mediated protein transport between the Golgi complex and the endoplasmic reticulum. Hydrolysis of ARF1-bound GTP may lead to dissociation of coatomer from Golgi-derived membranes to allow fusion with target membranes..
Protein Sequence MAAEPNKTEIQTLFKRLRAVPTNKACFDCGAKNPSWASITYGVFLCIDCSGVHRSLGVHLSFIRSTELDSNWNWFQLRCMQVGGNANATAFFRQHGCTANDANTKYNSRAAQMYREKIRQLGSAALARHGTDLWIDNMSSAVPNHSPEKKDSDFFTEHTQPPAWDAPATEPSGTQQPAPSTESSGLAQPEHGPNTDLLGTSPKASLELKSSIIGKKKPAAAKKGLGAKKGLGAQKVSSQSFSEIERQAQVAEKLREQQAADAKKQAEESMVASMRLAYQELQIDRKKEEKKLQNLEGKKREQAERLGMGLVSRSSVSHSVLSEMQVIEQETPVSAKSSRSQLDLFDDVGTFASGPPKYKDNPFSLGESFGSRWDTDAAWGMDRVEEKEPEVTISSIRPISERATNRREVESRSSGLESSEARQKFAGAKAISSDMFFGREVDAEYEARSRLQQLSGSSAISSSDLFGDMDGAHGAGSVSLGNVLPTADIAQFKQGVKSVAGKMAVLANGVMNSLQDRYGSY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAAEPNKTE
------CCCCCCHHH
22.1122814378
7Ubiquitination-MAAEPNKTEIQTLF
-CCCCCCHHHHHHHH
59.24-
8PhosphorylationMAAEPNKTEIQTLFK
CCCCCCHHHHHHHHH
44.9820068231
15UbiquitinationTEIQTLFKRLRAVPT
HHHHHHHHHHCCCCC
54.35-
24MalonylationLRAVPTNKACFDCGA
HCCCCCCCCHHHCCC
49.3526320211
24UbiquitinationLRAVPTNKACFDCGA
HCCCCCCCCHHHCCC
49.35-
88 (in isoform 2)Phosphorylation-9.6328348404
93 (in isoform 2)Phosphorylation-22.5728348404
94 (in isoform 2)Phosphorylation-31.9728348404
102UbiquitinationHGCTANDANTKYNSR
CCCCCHHHCHHHHHH
25.96-
105UbiquitinationTANDANTKYNSRAAQ
CCHHHCHHHHHHHHH
42.09-
123PhosphorylationEKIRQLGSAALARHG
HHHHHHHHHHHHHHC
20.97-
131PhosphorylationAALARHGTDLWIDNM
HHHHHHCCCEEEECC
23.0723927012
139PhosphorylationDLWIDNMSSAVPNHS
CEEEECCCCCCCCCC
22.7722167270
140PhosphorylationLWIDNMSSAVPNHSP
EEEECCCCCCCCCCC
23.6322167270
146PhosphorylationSSAVPNHSPEKKDSD
CCCCCCCCCCCCCCC
41.2022167270
152PhosphorylationHSPEKKDSDFFTEHT
CCCCCCCCCCCCCCC
45.2426074081
156PhosphorylationKKDSDFFTEHTQPPA
CCCCCCCCCCCCCCC
27.1821406692
159PhosphorylationSDFFTEHTQPPAWDA
CCCCCCCCCCCCCCC
36.2221406692
169PhosphorylationPAWDAPATEPSGTQQ
CCCCCCCCCCCCCCC
47.5821406692
172PhosphorylationDAPATEPSGTQQPAP
CCCCCCCCCCCCCCC
48.5221406692
174PhosphorylationPATEPSGTQQPAPST
CCCCCCCCCCCCCCC
28.5021406692
180PhosphorylationGTQQPAPSTESSGLA
CCCCCCCCCCCCCCC
47.0818669648
181PhosphorylationTQQPAPSTESSGLAQ
CCCCCCCCCCCCCCC
38.5421406692
183PhosphorylationQPAPSTESSGLAQPE
CCCCCCCCCCCCCCC
29.7826074081
184PhosphorylationPAPSTESSGLAQPEH
CCCCCCCCCCCCCCC
31.4326074081
191AcetylationSGLAQPEHGPNTDLL
CCCCCCCCCCCCCCC
64.79-
195PhosphorylationQPEHGPNTDLLGTSP
CCCCCCCCCCCCCCC
31.0230576142
200PhosphorylationPNTDLLGTSPKASLE
CCCCCCCCCCCHHHH
41.6526074081
201PhosphorylationNTDLLGTSPKASLEL
CCCCCCCCCCHHHHH
23.7028348404
205PhosphorylationLGTSPKASLELKSSI
CCCCCCHHHHHHHHH
28.6223403867
209UbiquitinationPKASLELKSSIIGKK
CCHHHHHHHHHCCCC
32.55-
210PhosphorylationKASLELKSSIIGKKK
CHHHHHHHHHCCCCC
39.1223403867
211PhosphorylationASLELKSSIIGKKKP
HHHHHHHHHCCCCCH
19.3523403867
215AcetylationLKSSIIGKKKPAAAK
HHHHHCCCCCHHHHH
47.4125953088
215UbiquitinationLKSSIIGKKKPAAAK
HHHHHCCCCCHHHHH
47.41-
222AcetylationKKKPAAAKKGLGAKK
CCCHHHHHHCCCCCC
42.527975635
223AcetylationKKPAAAKKGLGAKKG
CCHHHHHHCCCCCCC
55.427975645
228AcetylationAKKGLGAKKGLGAQK
HHHCCCCCCCCCCCC
45.647975655
229UbiquitinationKKGLGAKKGLGAQKV
HHCCCCCCCCCCCCC
59.85-
235UbiquitinationKKGLGAQKVSSQSFS
CCCCCCCCCCCCCHH
43.48-
237PhosphorylationGLGAQKVSSQSFSEI
CCCCCCCCCCCHHHH
29.6923401153
238PhosphorylationLGAQKVSSQSFSEIE
CCCCCCCCCCHHHHH
32.6025072903
240PhosphorylationAQKVSSQSFSEIERQ
CCCCCCCCHHHHHHH
32.4629255136
242PhosphorylationKVSSQSFSEIERQAQ
CCCCCCHHHHHHHHH
42.8029255136
250UbiquitinationEIERQAQVAEKLREQ
HHHHHHHHHHHHHHH
9.23-
252UbiquitinationERQAQVAEKLREQQA
HHHHHHHHHHHHHHH
54.49-
253AcetylationRQAQVAEKLREQQAA
HHHHHHHHHHHHHHH
43.0125953088
253UbiquitinationRQAQVAEKLREQQAA
HHHHHHHHHHHHHHH
43.01-
269PhosphorylationAKKQAEESMVASMRL
HHHHHHHHHHHHHHH
15.2928555341
270SulfoxidationKKQAEESMVASMRLA
HHHHHHHHHHHHHHH
3.1021406390
273PhosphorylationAEESMVASMRLAYQE
HHHHHHHHHHHHHHH
7.9428857561
278PhosphorylationVASMRLAYQELQIDR
HHHHHHHHHHHHCCH
13.7021945579
290UbiquitinationIDRKKEEKKLQNLEG
CCHHHHHHHHHHCCC
60.9321890473
291UbiquitinationDRKKEEKKLQNLEGK
CHHHHHHHHHHCCCH
59.59-
298AcetylationKLQNLEGKKREQAER
HHHHCCCHHHHHHHH
39.0023749302
298UbiquitinationKLQNLEGKKREQAER
HHHHCCCHHHHHHHH
39.00-
308SulfoxidationEQAERLGMGLVSRSS
HHHHHHCCCCCCHHH
4.4321406390
312PhosphorylationRLGMGLVSRSSVSHS
HHCCCCCCHHHCCHH
31.3323186163
314PhosphorylationGMGLVSRSSVSHSVL
CCCCCCHHHCCHHHH
27.8223401153
315PhosphorylationMGLVSRSSVSHSVLS
CCCCCHHHCCHHHHH
26.9121712546
317PhosphorylationLVSRSSVSHSVLSEM
CCCHHHCCHHHHHHC
16.4021712546
319PhosphorylationSRSSVSHSVLSEMQV
CHHHCCHHHHHHCEE
19.7621712546
322UbiquitinationSVSHSVLSEMQVIEQ
HCCHHHHHHCEEEEE
28.9421890473
322PhosphorylationSVSHSVLSEMQVIEQ
HCCHHHHHHCEEEEE
28.9421712546
331PhosphorylationMQVIEQETPVSAKSS
CEEEEECCCCCCCCC
28.7828450419
334PhosphorylationIEQETPVSAKSSRSQ
EEECCCCCCCCCHHH
31.0525159151
336AcetylationQETPVSAKSSRSQLD
ECCCCCCCCCHHHHH
41.2725953088
336UbiquitinationQETPVSAKSSRSQLD
ECCCCCCCCCHHHHH
41.27-
337PhosphorylationETPVSAKSSRSQLDL
CCCCCCCCCHHHHHC
30.6023401153
338PhosphorylationTPVSAKSSRSQLDLF
CCCCCCCCHHHHHCC
34.9325159151
340PhosphorylationVSAKSSRSQLDLFDD
CCCCCCHHHHHCCCC
36.7225159151
350PhosphorylationDLFDDVGTFASGPPK
HCCCCCCCCCCCCCC
18.8423403867
353PhosphorylationDDVGTFASGPPKYKD
CCCCCCCCCCCCCCC
47.8723186163
357UbiquitinationTFASGPPKYKDNPFS
CCCCCCCCCCCCCCC
68.98-
358PhosphorylationFASGPPKYKDNPFSL
CCCCCCCCCCCCCCC
29.3724702127
359UbiquitinationASGPPKYKDNPFSLG
CCCCCCCCCCCCCCC
58.09-
364PhosphorylationKYKDNPFSLGESFGS
CCCCCCCCCCCCCCC
36.4023927012
368PhosphorylationNPFSLGESFGSRWDT
CCCCCCCCCCCCCCC
32.8622167270
371PhosphorylationSLGESFGSRWDTDAA
CCCCCCCCCCCCCCC
28.3422167270
387UbiquitinationGMDRVEEKEPEVTIS
CCCCCCCCCCCEEEE
66.13-
392PhosphorylationEEKEPEVTISSIRPI
CCCCCCEEEEECCCC
17.3023312004
394PhosphorylationKEPEVTISSIRPISE
CCCCEEEEECCCCCH
15.4524719451
395PhosphorylationEPEVTISSIRPISER
CCCEEEEECCCCCHH
20.8325954137
400PhosphorylationISSIRPISERATNRR
EEECCCCCHHHCCHH
24.5825159151
404PhosphorylationRPISERATNRREVES
CCCCHHHCCHHHHHH
35.1624719451
413PhosphorylationRREVESRSSGLESSE
HHHHHHHHCCCCCHH
37.7329507054
414PhosphorylationREVESRSSGLESSEA
HHHHHHHCCCCCHHH
46.4125159151
418PhosphorylationSRSSGLESSEARQKF
HHHCCCCCHHHHHHH
38.2225159151
419PhosphorylationRSSGLESSEARQKFA
HHCCCCCHHHHHHHC
26.3721815630
429AcetylationRQKFAGAKAISSDMF
HHHHCCCCHHCCCCC
45.3925953088
429UbiquitinationRQKFAGAKAISSDMF
HHHHCCCCHHCCCCC
45.3921890473
432PhosphorylationFAGAKAISSDMFFGR
HCCCCHHCCCCCCCC
25.7429255136
433PhosphorylationAGAKAISSDMFFGRE
CCCCHHCCCCCCCCC
27.2930266825
435SulfoxidationAKAISSDMFFGREVD
CCHHCCCCCCCCCCC
3.0321406390
445PhosphorylationGREVDAEYEARSRLQ
CCCCCHHHHHHHHHH
19.3320007894
458PhosphorylationLQQLSGSSAISSSDL
HHHHHCCCCCCHHHC
32.9028348404
461PhosphorylationLSGSSAISSSDLFGD
HHCCCCCCHHHCCCC
24.4128348404
462PhosphorylationSGSSAISSSDLFGDM
HCCCCCCHHHCCCCC
23.0428348404
463PhosphorylationGSSAISSSDLFGDMD
CCCCCCHHHCCCCCC
31.3828348404
477PhosphorylationDGAHGAGSVSLGNVL
CCCCCCCCCCCCCCC
14.1728348404
479PhosphorylationAHGAGSVSLGNVLPT
CCCCCCCCCCCCCCC
32.0528348404
498PhosphorylationQFKQGVKSVAGKMAV
HHHHHHHHHHHHHHH
18.1322817900
513PhosphorylationLANGVMNSLQDRYGS
HHHHHHHHHHHHHCC
14.8714702039
520PhosphorylationSLQDRYGSY------
HHHHHHCCC------
20.8022199227

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ARFG2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ARFG2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ARFG2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MTND_HUMANADI1physical
26344197
ARFG1_HUMANARFGAP1physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ARFG2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146; SER-368 ANDSER-432, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-432, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146; SER-368 ANDSER-432, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146 AND SER-368, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146 AND SER-498, ANDMASS SPECTROMETRY.

TOP